LexDanaLexDanabeta
Inventor

PETER BRAMS

Inventor
US

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
G01NInvestigating or analysing materials by determining their chemical or physical properties18%
PatentTitleYear
12,372,536Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof202511,474,112Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof202211,312,777Human monoclonal antibodies that bind CXCR4 and uses thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to BRISTOL MYERS SQUIBB CO (3)· patent assignee history
2022–2025Patents assigned to PFIZER (2)· patent assignee history
2022Patents assigned to SQUIBB & SONS LLC (1)· patent assignee history
2022–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO32022–2025
PFIZER22022–2025
SQUIBB & SONS LLC12022
Locations
LocationPatentsSpan
US32022–2025